Journals / Nöropsikiyatri Arşivi / 2015 / Cilt: 52 - Sayı: 2

Parkinson Hastalığı Yaşam Kalitesi Sorgulama Formu (PDQL-TR)"nun Türkçe Versiyon Çalışması

Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL)

Pages
128–132
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

PDQLTR is a valid and reliable tool to measure health-related quality of life in patients with Parkinson's disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: This study aimed to evaluate Turkish transcultural adaptation, reliability, and validity of "Parkinson's Disease Quality of Life Questionnaire" (PDQL), which has been developed to assess the quality of life of patients with Parkinson's disease.
📊
Key Findings & Data:They were presented to the outpatient clinic of the Istanbul Faculty of Medicine, Physical Medicine and Rehabilitation department between July 2005 and April 2008.
💡
Conclusion & Impact:PDQLTR is a valid and reliable tool to measure health-related quality of life in patients with Parkinson's disease.
🔬Design:Survey & Empirical Study
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: This study aimed to evaluate Turkish transcultural adaptation, reliability, and validity of "Parkinson's Disease Quality of Life Questionnaire" (PDQL), which has been developed to assess the quality of life of patients with Parkinson's disease. Methods: Eighty-nine patients who were included in the study were diagnosed with Parkinson's disease. They were presented to the outpatient clinic of the Istanbul Faculty of Medicine, Physical Medicine and Rehabilitation department between July 2005 and April 2008. The Turkish translated version of PDQL (PDQL-TR), "Unified Parkinson's Disease Rating Scale" (UPDRS), and Hoehn & Yahr (HY) were used as the main outcome measures. Results: The calculated Pearson correlation coefficient for PDQL, H&Y, and UPDRS ranged between -0.36 and -0.80. Cronbach's alpha coefficients of the PDQL-TR complete questionnaire and subdomains were higher than 0.80. The absolute value of item-total score correlation coefficients by Pearson fluctuated between 0.40 (question 4-total score) and 0.88 (question 26-total score), whereas the subdomain-total score correlation coefficients ranged between 0.81 and 0.96. PDQL-TR showed high stability according to the ICC results, ranging between 0.75 (Emotional Function) and 0.88 (Parkinsonian Symptoms). Conclusion: The psychometric features of PDQL-TR are satisfactory, and our results are consistent with the previous literature findings. PDQLTR is a valid and reliable tool to measure health-related quality of life in patients with Parkinson's disease.

Özet

Amaç: Bu çalışma Parkinson hastalığı olan hastaların yaşam kalitesini de- ğerlendirmek için geliştirilen "Parkinson Hastalığı Yaşam Kalitesi Sorgulama Formu'nun (PDQL-TR)" Türkçe kültürel adaptasyonunu, geçerlilik ve gü- venilirliğini araştırmayı amaçlamıştır. Yöntem: İstanbul Üniversitesi İstanbul Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı'nın polikliniğine Haziran 2005-Nisan 2008 tarihleri arasında başvuran, Parkinson hastalığı tanısı almış 89 hasta çalışmaya dahil edilmiştir. PDQL'in Türkçe versiyonu (PDQL-TR), "Birleştirilmiş Parkinson Hastalığı Derecelendirme Ölçeği" (UPDRS), "Hoehn & Yahr (H & Y) skalası" temel sonuç ölçüm yöntemleri olarak kullanıdı. Bulgular: PDQL-TR, H&Y ve UPDRS skalaları için hesaplanmış Pearson korelasyon katsayısı -0,36 ve-0,80 arasında değişmekteydi. PDQL-TR sorgulama formunun total ve alt grup skorlarının Cronbach alpha katsayısı 0,80'den yüksekti. Madde toplam puan değeri Pearson korelasyon kat sayı- sı 0,40 (4.soru-toplam skor) ve 0,88 (26. soru-toplam skor) arasında değiş- mekteydi, alt-grup toplam skorlarının korelasyon katsayıları ise 0,81 ile 0,96 arasındaydı. PDQL-TR'nin sınıf içi korelasyon sonuçları 0,75 (emosyonel fonksiyon) ve 0,88 (Parkinson semptomları) aralığında yer alarak, yüksek stabilite göstermiştir. Sonuç: PDQL-TR'nin psikometrik özellikleri memnuniyet vericidir ve sonuçlarımız önceki literatür bulgularıyla uyum göstermektedir. PDQL-TR Parkinson hastalığı olan hastaların sağlıkla ilişkili yaşam kalitelerini ölçmede geçerli ve güvenilir bir sorgulama formudur.

🔖

Cite This Article

DERELİ, E. E., YALIMAN, A., ÇOLAKA, T. K., REYHAN, A. Ç., ÖZDİNÇLER, A. R., DEMİRBAŞ, F. Ş. B. (2015). Parkinson Hastalığı Yaşam Kalitesi Sorgulama Formu (PDQL-TR)"nun Türkçe Versiyon Çalışması. Nöropsikiyatri Arşivi, Cilt: 52 - Sayı: 2, 128–132. https://ajindex.com/articles/292386

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 2003; 991:1-14. [CrossRef] Martinez-Martin P. An introduction to the concept of ''quality of life in Parkin- son's disease''. J Neurol 1998; 245(Suppl 1):S2-6. [CrossRef] Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 2006; 248:151-157. [CrossRef] Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000; 15:1112-1118. [CrossRef] Netuveli G, Wiggins RD, Hildon Z, Montgomery SM, Blane D. Functional lim- itation in long standing illness and quality of life: evidence from a national survey. BMJ 2005; 331:1382-1383. [CrossRef] Devinsky O. Outcome research in neurology: incorporating health- related quality of life. Ann Neurol 1995; 37:141-142. [CrossRef] Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM. Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry 2002; 72:241-248. [CrossRef] Jenkinson C, Fitzpatrick R, Peto V. Health-related quality of life measurement in pa- tients with Parkinson's disease. Pharmacoeconomics 1999; 15:157-165. [CrossRef] Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. CMAJ 1986; 134:889-895.
  2. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and vali- dation of a short measure of functioning and well-being for individuals with Parkinson's disease. Qual Life Res 1995; 4:241-248. [CrossRef] de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996; 61:70-74. [CrossRef] Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J. Devel- opent and testing of the. Parkinson's disease quality of life scale. Mov Disord 2003; 18:637-645. [CrossRef] Yousefi B, Tadibi V, Khoei AF, Montazeri A. Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial. Trials 2009; 10:67. [CrossRef] Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, Athen O, Köhne-Volland R, Dodel RC. Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study. Parkinsonism and Relat Disord 2007; 13:108-114. [CrossRef] MAPI Institute Web Page. Linguisti